(TBI) TrueBlue - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US89785X1019
TBI: Staffing, Recruitment, Workforce, Solutions, Services
TrueBlue, Inc. (NYSE:TBI) is a provider of specialized workforce solutions, operating across the United States, Canada, the United Kingdom, Australia, and Puerto Rico. The company is structured into three core segments: PeopleReady, PeopleManagement, and PeopleScout. PeopleReady focuses on contingent staffing services for industries such as construction, manufacturing, and retail, offering both general and skilled trade labor. PeopleManagement provides on-site industrial staffing and commercial driver services, leveraging brands like Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers to serve manufacturing, warehousing, and transportation sectors. PeopleScout, the recruitment process outsourcing division, delivers talent advisory services, managed service provider solutions, and operates Affinix, a technology platform for permanent workforce sourcing. The company, rebranded from Labor Ready, Inc. in 2007, has been in operation since 1985 and is headquartered in Tacoma, Washington.
From a technical perspective, TBI is currently trading at $5.63, below its SMA 20 ($7.01), SMA 50 ($7.58), and SMA 200 ($8.54) levels, indicating bearish momentum. The Average True Range (ATR) of 0.39 suggests reduced volatility in recent trading sessions. Fundamental analysis highlights a market capitalization of $183.89 million, with a forward P/E ratio of 56.18, reflecting investor expectations of future earnings growth despite a current P/E ratio of 0.00. The price-to-book ratio of 0.58 and price-to-sales ratio of 0.12 indicate undervaluation relative to book value and revenue, though the negative return on equity (-39.87%) signals ongoing profitability challenges.
Over the next three months, TBI is expected to face continued downward pressure, with the stock price potentially testing lower support levels near $5.00 due to the bearish crossover of its short- and long-term moving averages. However, the low ATR may limit significant downside volatility. Fundamental trends suggest the market is pricing in expectations of a turnaround in profitability, given the high forward P/E ratio, but near-term risks remain elevated due to the negative RoE and macroeconomic uncertainties impacting labor markets. Investors should monitor earnings reports and management guidance for signs of operational improvement.
Additional Sources for TBI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TBI Stock Overview
Market Cap in USD | 169m |
Sector | Industrials |
Industry | Staffing & Employment Services |
GiC Sub-Industry | Human Resource & Employment Services |
IPO / Inception | 1996-06-13 |
TBI Stock Ratings
Growth 5y | -66.5% |
Fundamental | -60.2% |
Dividend | 0.0% |
Rel. Strength Industry | -53.9 |
Analysts | 4/5 |
Fair Price Momentum | 4.41 USD |
Fair Price DCF | - |
TBI Dividends
No Dividends PaidTBI Growth Ratios
Growth Correlation 3m | -85.4% |
Growth Correlation 12m | -79.3% |
Growth Correlation 5y | -59.9% |
CAGR 5y | -14.24% |
CAGR/Max DD 5y | -0.17 |
Sharpe Ratio 12m | -0.27 |
Alpha | -61.53 |
Beta | 1.17 |
Volatility | 47.01% |
Current Volume | 213.2k |
Average Volume 20d | 216k |
As of March 15, 2025, the stock is trading at USD 5.83 with a total of 213,169 shares traded.
Over the past week, the price has changed by +2.28%, over one month by -22.37%, over three months by -34.93% and over the past year by -49.70%.
No, based on ValueRay Fundamental Analyses, TrueBlue (NYSE:TBI) is currently (March 2025) a stock to sell. It has a ValueRay Fundamental Rating of -60.18 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TBI as of March 2025 is 4.41. This means that TBI is currently overvalued and has a potential downside of -24.36%.
TrueBlue has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy TBI.
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, TBI TrueBlue will be worth about 4.9 in March 2026. The stock is currently trading at 5.83. This means that the stock has a potential downside of -15.27%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 10.7 | 83% |
Analysts Target Price | 11.7 | 100.2% |
ValueRay Target Price | 4.9 | -15.3% |